ELECSYS PROLACTIN ASSAY 03203093190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-12-22 for ELECSYS PROLACTIN ASSAY 03203093190 manufactured by Roche Diagnostics.

Event Text Entries

[63206398] This event occurred in (b)(6). (b)(4). Medwatch field expiration date was provided as february 2017. (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[63206399] The customer stated that they received erroneous results for one patient sample tested for the elecsys prolactin assay (prl) on a cobas e 411 immunoassay analyzer (e411). The patient sample initially resulted as 78. 47 ng/ml and this value was reported outside of the laboratory. The sample was also repeated on (b)(6) 2016, resulting as 74. 29 ng/ml. A new sample was collected from the patient and tested on a centaur analyzer on (b)(6) 2016, resulting as 18. 80 ng/ml. A result value of 12. 7 ng/ml from (b)(6) 2016 was also provided, but it is not clear if this result was from the initial sample, the new sample, from a different patient sample, or if it had been documented in error. A clarification has been requested. The patient was not adversely affected. The serial number of the e411 analyzer was asked for, but not provided.
Patient Sequence No: 1, Text Type: D, B5


[63387735] It has been confirmed that the value of the new sample tested on the centaur analyzer on (b)(6) 2016 was actually 12. 7 ng/ml. The value of 18. 80 ng/ml was provided in error.
Patient Sequence No: 1, Text Type: N, H10


[68569252] A specific root cause could not be determined based on the provided information. Additional information required for the investigation was requested, but not provided. No general reagent issue is evident. Different prl levels were measured with the roche method and the centaur method, but direct comparison measurements of the two methods were not performed with either of the two samples. Based on available data, it could not be confirmed if there is really a discrepancy between the two methods. Possible differences in results may occur if the patient has macro-prolactin in their serum. The presence of macro-prolactin in the sample would yield a higher value with the roche prl method. The two samples may also not have been from the same patient, but this could not be confirmed. Clinical differences in prl levels may also occur over several days.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2016-02046
MDR Report Key6198299
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-12-22
Date of Report2017-02-24
Date of Event2016-11-12
Date Mfgr Received2016-11-30
Date Added to Maude2016-12-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameELECSYS PROLACTIN ASSAY
Generic NameRADIOIMMUNOASSAY, PROLACTIN (LACTOGEN)
Product CodeCFT
Date Received2016-12-22
Model NumberNA
Catalog Number03203093190
Lot Number188354
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device Availability*
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2016-12-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.